BIN2 anticorps (AA 290-496)
-
- Antigène Voir toutes BIN2 Anticorps
- BIN2 (Bridging Integrator 2 (BIN2))
-
Épitope
- AA 290-496
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp BIN2 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Bridging integrator 2 protein (290-496AA)
- Isotype
- IgG
-
-
- Indications d'application
- Recommended dilution: IHC:1:20-1:200, IF:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- BIN2 (Bridging Integrator 2 (BIN2))
- Autre désignation
- BIN2 (BIN2 Produits)
- Synonymes
- anticorps BRAP-1, anticorps BIN2, anticorps bin2l, anticorps wu:fi05e01, anticorps zgc:55758, anticorps bridging integrator 2, anticorps bridging integrator 2b, anticorps BIN2, anticorps Bin2, anticorps bin2b
- Sujet
-
Background: Promotes cell motility and migration, probably via its interaction with the cell membrane and with podosome proteins that mediate interaction with the cytoskeleton. Modulates membrane curvature and mediates membrane tubulation. Plays a role in podosome formation. Inhibits phagocytosis.
Aliases: BIN2 antibody, BRAP1Bridging integrator 2 antibody, Breast cancer-associated protein 1 antibody
- UniProt
- Q9UBW5
-